28.05.2013 Views

Securitas AB Annual Report 2005

Securitas AB Annual Report 2005

Securitas AB Annual Report 2005

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Recognition and subsequent measurement<br />

Purchases and sales of fi nancial instruments are recognised on trade-date – the<br />

date on which the Group commits to purchase or sell the instrument.<br />

Financial instruments are initially recognized at fair value plus transaction<br />

costs for all fi nancial assets or fi nancial liabilities not carried at fair value through<br />

profi t or loss.<br />

Financial assets are derecognized when the rights to receive cash fl ows from<br />

the instruments have expired or have been transferred and the Group has transferred<br />

substantially all risks and rewards of ownership. Financial liabilities are<br />

removed when the obligation is discharged, cancelled or expired.<br />

Financial assets or fi nancial liabilities at fair value through profi t or loss and<br />

available-for-sale fi nancial assets are subsequently carried at fair value. Loans and<br />

receivables and held-to-maturity investments are carried at amortized cost using<br />

the effective interest method. Realised and unrealised gains and losses arising<br />

from changes in the fair value of the fi nancial assets or liabilities at fair value<br />

through profi t or loss category are included in the income statement in the period<br />

in which they arise. Financial liabilities with the exception of fi nancial liabilities at<br />

fair value through profi t or loss and fi nancial liabilities designated for hedging are<br />

subsequently carried at amortized cost. Financial liabilities designated for hedging<br />

that qualify for fair value hedge accounting are subsequently carried at fair value.<br />

Changes in the fair value are included in the income statement in the period in<br />

which they arise. The corresponding gain or loss from re-measuring the hedging<br />

instrument at fair value is also included in the income statement in the same period<br />

as that in which the gain or loss on the hedged item arises. Cash fl ow hedging<br />

instruments are carried at fair value in the balance sheet and the gain or loss from<br />

re-measuring the hedging instrument at fair value are recognized in the hedging<br />

reserve in equity with a reversal from the hedging reserve to the statement of<br />

income in the period of which the cash fl ow of the hedged item impacts the statement<br />

of income. Exchange rate gains and losses on derivatives that are part of a<br />

net investment hedge relationship are recognized in equity.<br />

Actual cash fl ows that arise from derivative instruments are recognized as<br />

interest income and/or interest expense in the period to which they relate. Changes in<br />

fair value for both the hedged instrument and the hedging instrument (derivative) is<br />

recognized separately as Revaluation of fi nancial instruments. The line Revaluation<br />

of fi nancial instruments is included within Financial income and/or Financial<br />

expense. The separation of the result in interest and revaluation effects increases<br />

the ability to compare the effects with the effects under Swedish GAAP as well as<br />

separating unrealized changes in fair value from the actual cash fl ows that forms<br />

the basis for recognition of both interest income and interest expense.<br />

The fair values of quoted fi nancial instruments are based on current bid prices.<br />

If the market for a fi nancial instrument is not active (and for unlisted securities),<br />

the Group establishes fair value by using valuation techniques. These include the<br />

use of recent arm’s length transactions, reference to other instruments that are<br />

substantially the same, discounted cash fl ow analysis, and option pricing models<br />

refi ned to refl ect the issuer’s specifi c circumstances.<br />

Impairment of fi nancial assets<br />

The Group assesses at each balance sheet date whether there is objective evidence<br />

that a fi nancial asset or a group of fi nancial assets is impaired.<br />

Financial Instruments: Recognition and Measurement (IFRS 2004 and<br />

Swedish GAAP 2004) – to December 31, 2004<br />

Financial Instruments: Disclosure and Presentation<br />

IAS 32 (and according to Swedish GAAP, RR 27) Financial Instruments: Disclosure<br />

and Presentation stipulates the balance sheet classifi cation of fi nancial instruments<br />

and the disclosures to facilitate understanding of how fi nancial instruments<br />

infl uence income, fi nancial position and cash fl ow. The recommendation does not<br />

stipulate when fi nancial instruments should be recognized, or de-recognized from<br />

the balance sheet, nor does it indicate how such fi nancial instruments should be<br />

valued.<br />

Short-term investments<br />

Short-term investments are accounted according to the lower of cost or market<br />

principle if they pertain to transferable securities, and at acquisition value for bank<br />

deposits.<br />

Convertible debenture loans<br />

Convertible debenture loans are compound fi nancial instruments whose fi nancial<br />

liability (the loan) and the shareholders’ equity-related instrument (the issued put)<br />

should be accounted separately at the time of issue. Because the convertible debenture<br />

loan 2002/2007 series 1–4 was issued at market interest, the related shareholders’<br />

equity-related instrument constituted an insignifi cant portion of the issue<br />

proceeds, whereupon the convertible debenture loan was classifi ed as a fi nancial<br />

liability in its entirety.<br />

Notes and comments to the consolidated fi nancial statements<br />

Bond loans issued<br />

Bond loans issued are accounted at amortized cost, which means the present value<br />

of future payments calculated by the effective historical rate of interest at the time<br />

of issue.<br />

Commercial paper issued<br />

Commercial paper has been issued as part of a short-term Swedish commercial<br />

paper program and accounted under Other short-term loan liabilities at the original<br />

settlement value. Accrued interest is accounted under Accrued interest expenses<br />

using a linear valuation method. Due to the short tenor of issued commercial<br />

paper, the difference between accrued interest estimated linearly and by discounting<br />

is immaterial.<br />

Derivatives<br />

Loan receivables and loan liabilities hedged through forward currency contracts are<br />

valued at the spot rate on the day the hedge was entered into. Forward premiums<br />

and discounts, that is the difference between the forward rate and the spot rate,<br />

are accounted as interest.<br />

Interest rate derivatives are used for hedging purposes only and accounted<br />

through the deferral of unrealized gains and losses, known as deferral hedge<br />

accounting. As a result, the Group’s gains or losses from interest rate derivatives –<br />

comprises only interest income and interest expenses based on actual cash fl ows<br />

from interest rate derivatives. Option premiums paid are expensed over the term<br />

of the hedged position and are accounted as interest expenses.<br />

Employee Benefi ts (IAS 19)<br />

The Group operates or participates in a number of defi ned benefi t and defi ned contribution<br />

pension and other long-term employee benefi t plans. Other plans primarily<br />

relates to healthcare benefi ts. Calculations for the defi ned benefi t plans that exist<br />

within <strong>Securitas</strong> are carried out yearly by independent actuaries.<br />

Costs for defi ned benefi t plans are estimated using the so-called Projected Unit<br />

Credit method in a way that distributes the cost over the employee’s working life.<br />

Obligations are valued at the present value of the expected future cash fl ows using<br />

a discount interest rate corresponding to the interest rate on high quality corporate<br />

bonds or government bonds with remaining term that is approximately the same as<br />

the obligations. Plan assets are measured at fair value.<br />

Gains and losses resulting from changes in actuarial assumptions, plan experience<br />

and investment performance differing from that assumed are spread evenly in<br />

the income statement over the future working life of the employees in the plan to<br />

the extent that the accumulated gains and losses at the balance sheet date fall outside<br />

the so called corridor at the start of the period. This corridor corresponds to<br />

10 percent of the higher of the defi ned benefi t obligation and the value of plan<br />

assets at the balance sheet date.<br />

If accounting for a defi ned benefi t plan results in a balance sheet asset, this is<br />

reported as a net asset in the consolidated balance sheet under Other long-term<br />

receivables. Otherwise it is reported as a provision under Provisions for pensions<br />

and similar commitments. Costs related to defi ned benefi t plans, including the<br />

interest element, are accounted for in operating income. Provisions for pensions<br />

and similar commitments are not included in net debt.<br />

Payments under defi ned contribution plans are recognized in the period in<br />

which the employees have rendered their services. The expense is taken as the<br />

contributions payable during the period.<br />

Share-based payments (IFRS 2)<br />

IFRS 2 requires that the fair value of the equity settled schemes should be accounted<br />

for as an expense in the statement of income with the corresponding entry accounted<br />

for as equity. The expense should be accrued for on a linear basis over the vesting<br />

period. For cash settled schemes IFRS 2 also requires that the fair value of the<br />

scheme should be accounted for as an expense in the statement of income on a<br />

linear basis over the vesting period, but with the corresponding entry recognized<br />

as a liability rather than as equity. Furthermore if the incentive scheme lapses<br />

without settlement this will result in a reversal of the accrued cost for cash settled<br />

schemes only. For equity settled schemes no reversal will occur since no adjustment<br />

to the net assets is required.<br />

<strong>Securitas</strong> have no equity settled or cash settled schemes that would fall within<br />

the scope of this standard.<br />

Provisions (IAS 37)<br />

Provisions are recognized when the Group has a present obligation as a result of<br />

a past event and it is probable that an outfl ow of resources embodying economic<br />

benefi ts will be required to settle the obligation and a reliable estimate can be<br />

made of the amount of the obligation.<br />

Claims reserves are calculated on the basis of a combination of case reserves,<br />

which represent claims reported, and IBNR (incurred but not reported) reserves.<br />

Actuarial calculations are performed quarterly to assess the adequacy of the<br />

reserves based on open claims and historical IBNR. The provisions are recognized<br />

in the balance sheet at the discounted value that has been established by the actuarial<br />

calculations.<br />

SECURITAS <strong>2005</strong> 83

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!